Role of communicable disease control measures in affecting the spread of resistant pneumococci: The Swedish model

Clinical Microbiology and Infection

Volumn 5, Issue SUPPL. 4, 1999, Pages S48-S54

  Ekdahl, Karl ^a   Cars, Otto ^b  

^a SWEDISH INSTITUTE FOR INFECTIOUS DISEASE CONTROL   (Sweden)

^b UPPSALA UNIVERSITY HOSPITAL   (Sweden)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIBIOTIC AGENT; PENICILLIN G;

ANTIBIOTIC RESISTANCE; BACTERIUM CARRIER; CONFERENCE PAPER; DISEASE DURATION; DRUG USE; HEALTH CARE POLICY; INFECTION CONTROL; MINIMUM INHIBITORY CONCENTRATION; PRIORITY JOURNAL; SEROTYPE; STREPTOCOCCUS INFECTION; STREPTOCOCCUS PNEUMONIAE; SWEDEN;

EID: 0345035493     PISSN: 1198743X     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1469-0691.1999.tb00857.x     Document Type: Conference Paper

References (32)

1. Appelbaum PC. Antimicrobial resistance in Streptococcus pneumoniae: an overview. Clin Infect Dis 1992; 15: 77-83.
2. Forsgren A, Walder M. Activity of common antibiotics against Branhamella catarrhalis, Haemophilus influenzae, pneumococci, group A streptococci and Staphylococcus aureus in 1983. Acta Otolaryngol Suppl (Stockh) 1984; 407: 43-9.
3. Olsson Liljequist B, Burman LG, Kallings I, Swedish Respiratory Tract Study Group. Antibiotic susceptibility of upper respiratory tract pathogens in Sweden: a seven year follow-up study including loracarbef. Scand J Infect Dis 1992; 24: 485-93.
4. Ekdahl K, Kamme C. Increasing resistance to penicillin in Streptococcus pneumoniae in southern Sweden. Scand J Infect Dis 1994; 26: 301-5.
5. Forsgren A, Walder M. Antimicrobial susceptibility of bacterial isolates in south Sweden including a 13-year follow-up study of some respiratory tract pathogens. APMIS 1994; 102: 227-35.
6. Christenson B, Sylvan SPE, Noreen B. Carriage of multiresistant Streptococcus pneumoniae among children attending day-care centres in the Stockholm area. Scand J Infect Dis 1997; 29: 555-8.
7. Henning C, Bengtsson L, Jorup C, Engquist S. Antibiotic resistance in Streptococcus pneumoniae, Haemophilus influenzae, and Streptococcus pyogenes in respiratory tract infections in outpatients. Scand J Infect Dis 1997; 29: 559-63.
8. Olsson-Liljequist B. Resistance development in Sweden. The Swedish Reference Group for Antibiotics (SRGA). Available from: URL: http://www.ltkronoberg.se/ext/raf/raf.htm
9. Tüll P, Burman LG, Eriksson M, Kalin M, Persson K. Pneumococci with reduced susceptibility to penicillin: background and analysis of the situation in Sweden 1995 [in Swedish]. Expert report. Stockholm: Socialstyrelsens Kundtjanst, 1997: 1-32.
10. Hedlund J, Olsson-Liljequist B. Control programme for antibiotic-resistant pneumococci; mandatory notification sometimes neglected by physicians. Läkartidningen 1997; 94: 4914-18.
11. Ekdahl K, Hansson HB, Mölstad S, Söderström M, Walder M, Persson K. Limiting the spread of penicillin-resistant Streptococcus pneumoniae: experiences from the South Swedish Pneumococcal Intervention Project. Microb Drug Resist 1998; 4: 99-105.
12. Kristinsson KG. Epidemiology of penicillin resistant pneumococci in Iceland. Microb Drug Resist 1995; 1: 121-5.
13. Privitera G. Penicillin resistance among Streptococcus pneumoniae in Europe. Diagn Microbiol Infect Dis 1994; 19: 157-61.
14. Nielsen SV, Henrichsen J. Capsular types of Streptococcus pneumoniae isolated from blood and CSF during 1982-1987. Clin Infect Dis 1992; 15: 794-8.
15. Butler JC, Breiman RF, Lipman HB, Hofmann J, Facklam RR. Serotype distribution of Streptococcus pneumoniae infections among preschool children in the United States, 1978-1994: implications for development of a conjugate vaccine. J Infect Dis 1995; 171: 885-9.
16. Nilsson P, Persson K, Laurell MH. Several clones at the introduction of penicillin-resistant pneumococci in Malmö [abstract MM1GP] [in Swedish]. Proceedings of the Yearly Conference of the Swedish Society of Medicine, November 1997. Stockholm: Hygiea, 1997: 247.
17. Melander E, Ekdahl K, Hansson HB, et al. Introduction and clonal spread of penicillin and trimethoprim/sulfamethoxazole-resistant Streptococcus pneumoniae, serotype 9V, in southern Sweden. Microb Drug Resist 1998; 4: 71-8.
18. Kihlström E, Normann B. Occurrence of pneumococci with resistance or decreased susceptibility to penicillin in southeast Sweden. Scand J Infect Dis 1995; 27: 489-94.
19. Ekdahl K, Melander E, Persson K. Examine adopted children for resistant pneumococci [Letter in Swedish]. Läkartidningen 1997; 94: 4726.
20. Ekdahl K, Ahlinder I, Hansson HB, et al. Duration of nasopharyngeal carriage of penicillin-resistant Streptococcus pneumoniae: experiences from the South Swedish Pneumococcal Intervention Project. Clin Infect Dis 1997; 25: 1113-17.
21. Gunnarsson O, Ekdahl K. Previous respiratory tract infections and antibiotic consumption in children with long- and short-term carriage of penicillin-resistant Streptococcus pneumoniae. Epidemiol Infect 1998; 121: 523-8.
22. Ekdahl K, Holmdahl T, Vejvoda M, Persson K. Eradication of penicillin-resistant Streptococcus pneumoniae in nasopharynx with antibiotic combinations including rifampicin: experiences from the South Swedish Pneumococcal Intervention Project. Scand J Infect Dis 1997; 29: 373-5.
23. Koornhof HJ, Jacobs MR, Ward JI, Appelbaum PC, Hallet FA. Therapy and control of antibiotic-resistant disease. In: Schlessinger D, ed. Microbiology - 1979. Washington DC: American Society for Microbiology, 1979: 286-9.
24. Cars O. Swedish strategic programme for the rational use of antimicrobial agents and surveillance of resistance. Available from: URL: http://www.strama.org/English/english.html
25. National Corporation of Pharmacies. The prescription study 1993-1997. Stockholm: Apoteksbolaget AB, 1998.
26. Centers for Disease Control and Prevention. Defining the public health impact of drug-resistant Streptococcus pneumoniae: report of a working group. MMWR 1996; 45(RR-1): 1-21.
27. Baquero F, the Task Force of the General Direction for Health Planning of the Spanish Ministry of Health. Antibiotic resistance in Spain: what could be done? Clin Infect Dis 1996; 23: 819-23.
28. Baquero F. Epidemiology and management of penicillin-resistant pneumococci. Curr Opin Infect Dis 1996; 9: 372-9.
29. Höiby N. Epidemiological aspects of antibiotic resistance. Microb Drug Resist 1995; 1: 137-42.
30. Klein DL. Pneumococcal conjugate vaccines: review and update. Microb Drug Resist 1995; 1: 49-58.
31. Käyhty H, Åhman H, Rönnberg PR, Tillikainen R, Eskola J. Pneumococcal polysaccharide-meningococcal outer' membrane protein complex conjugate vaccine is immunogenic in infants and children. J Infect Dis 1995; 172: 1273-8.
32. Dagan R, Melamed R, Muallem M, et al. Reduction of nasopharyngeal carriage of pneumococci during the second year of life by a heptavalent conjugate pneumococcal vaccine. J Infect Dis 1996; 174: 1271-8.